28 February 2011 Photothermal therapy of acute leukemia cells in the near-infrared region using gold nanorods CD-33 conjugates
Author Affiliations +
Abstract
In the present work, we demonstrate a potential use of gold nanorods as a contrast agent for selective photothermal therapy of human acute leukemia cells (HL-60) using a near-infrared laser. Gold Nanorods (GNR) are synthesized and conjugated to CD33, a 67 kDa glycoprotein found on the surface of myeloid cells that belongs to the sialoadhesin family of proteins. After pegylation, or conjugation with CD33 antibody, GNR were non-toxic for acute and chronic leukemia cells. We used a Quanta System q-switched titanium sapphire laser emitting at a center wavelength of 755 nm. Each sample was illuminated with 1 laser shot at either high or low fluence. Both laser modes were used in 3 independent cell probes. HL-60 cells were treated for 45 min with GNR conjugated with mAb CD33, or with GNR-Pegylated particles. After laser application, the cells were resuspended and analyzed to cell viability with Trypan blue exclusion assay. GNR-CD33 conjugates significantly increase the percentage of cell death as compared with a control group after laser illumination: a 3 fold increase is observed.
© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Anton Liopo, André Conjusteau, Marina Konopleva, Michael Andreeff, Alexander Oraevsky, "Photothermal therapy of acute leukemia cells in the near-infrared region using gold nanorods CD-33 conjugates", Proc. SPIE 7897, Optical Interactions with Tissue and Cells XXII, 789710 (28 February 2011); doi: 10.1117/12.878802; https://doi.org/10.1117/12.878802
PROCEEDINGS
8 PAGES


SHARE
RELATED CONTENT


Back to Top